Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001200876-25-000020·Iris Acquisition Holdings LLC
Schedule 13D ownership disclosure
LIMINATUS PHARMA INC.
Common Stock · CUSIP: 53271X108
Event date: 2025-04-30
- Filing-level shares
- 6,900,000.00
- Percent of class
- 26.5%
- Iris Acquisition Holdings LLCReported CIK 0002064461
Shares: 6,900,000.00 · Class: 26.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001200876-25-000020
- Form type
- SCHEDULE 13D
- Filer
- Iris Acquisition Holdings LLC
- CIK
- CIK 2064461
- Filed
- May 08, 2025
- Reporting period
- Apr 30, 2025
- Description
- Schedule 13D beneficial ownership